Overview and Testing Algorithms: Pregnant or Non-Pregnant Symptomatic Individuals

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 176 CE courses, most popular
$109Add to cart
Pick Your Courses
Up to 8 CE hours
$55Add to cart
Individual course$25Add to cart
The page below is a sample from the LabCE course Zika Virus: Overview and Laboratory Testing. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Zika Virus: Overview and Laboratory Testing (online CE course)
Overview and Testing Algorithms: Pregnant or Non-Pregnant Symptomatic Individuals

Note: For purposes of interpretation, a non-negative Zika virus IgM serology test result may include positive, equivocal, presumptive positive, or possible positive.
  • Symptomatic non-pregnant individuals with possible Zika virus exposure should be tested for the Zika virus as follows:
For specimens collected <14 days post-symptom onset, a Zika NAT test should be performed (such as an rRT-PCR test). If positive for NAT, the individual is considered to have an acute Zika virus infection. If negative for Zika NAT, the specimen should be further tested for Zika virus IgM serology.
For specimens collected 14 days post-symptom onset, no NAT is performed, but the specimen is tested directly for Zika IgM serology.
A negative test for Zika IgM indicates that the individual is considered to have no evidence of Zika virus infection. If non-negative for Zika virus IgM, then a PRNT test should be performed.
A PRNT Zika virus test 10 and a Dengue Virus PRNT <10 indicate a Zika virus infection, but the timing of infection cannot be determined.
A PRNT Zika virus test 10 and Dengue Virus PRNT 10 indicate a Flavivirus infection, but the timing of infection cannot be determined.
A PRNT Zika virus test of <10 indicates no evidence of Zika virus infection.
Note: See the accompanying algorithm for more details.
  • Symptomatic pregnant women with possible Zika virus exposure should be tested in the following manner:
Testing should be done as soon as possible through 12 weeks after symptom onset. The specimen should be tested by both NAT (serum and urine) and Zika virus IgM serology (serum).
If Zika virus NAT is positive, the individual is considered to have acute Zika virus infection.
If negative for Zika virus NAT and negative for Zika virus IgM serology, then the individual is considered to not have evidence of Zika virus infection.
If negative for Zika virus NAT and non-negative for IgM serology, the specimen should be tested by PRNT. If the Zika virus PRNT is <10, then the individual is considered to not have evidence of Zika virus infection.
If Zika virus PRNT is 10 and Dengue virus PRNT is <10, then the individual is considered to have a Zika virus infection, but the timing of infection cannot be determined.
If Zika virus PRNT is 10 and Dengue virus PRNT is 10, then a flavivirus infection is considered, and the specific virus and timing of infection cannot be determined.
NOTE: See the accompanying algorithm for more details.

Updated Zika test CDC Algorithm-Symptomatic non-pregnant. Source CDC
Updated Zika test CDC algorithm Symptomatic pregnant. Source: CDC